This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
PHARMAC.Disabling cardiovascular disease gets funded treatments. Media Release: 19 Jun 2009. Available from: URL: http://www.pharmac.govt.nz
About this article
Cite this article
Sildenafil, bosentan and iloprost will now be easier to access for pulmonary arterial hypertension patients in New Zealand. Pharmacoecon. Outcomes News 585, 10 (2009). https://doi.org/10.2165/00151234-200905850-00033
- Public Health
- Health Outcome
- Hypertension Patient
- Health Economic